{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:16:52Z","timestamp":1787725012792,"version":"build-2784847793"},"reference-count":83,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurol.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T23:02:39Z","timestamp":1479423759000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Molecular imaging in the diagnosis of Alzheimer's disease and related disorders"],"prefix":"10.1016","volume":"172","author":[{"given":"L.","family":"Koric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.O.","family":"Habert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Semah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Payoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Le Jeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.neurol.2016.10.009_bib0420","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2016.10.009_bib0425","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Maladie d\u2019Alzheimer et maladies apparent\u00e9es. HAS, www.has-sante.fr\/.\/maladie-d-alzheimer-et-maladies-apparentees-diagnostic-et-prise-en-charge."},{"issue":"12","key":"10.1016\/j.neurol.2016.10.009_bib0430","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0435","first-page":"240","article-title":"Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging","volume":"7","author":"Villringer","year":"1995","journal-title":"Cerebrovasc Brain Metab Rev"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0440","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.neurol.2016.10.009_bib0445","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0b013e31829d86e8","article-title":"ISTAART's NeuroImaging Professional Interest Area. Imaging markers for Alzheimer disease: which vs how","volume":"81","author":"Frisoni","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneur.1987.00520140035014","article-title":"Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123","volume":"44","author":"Johnson","year":"1987","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","article-title":"Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections","volume":"1","author":"Braak","year":"1991","journal-title":"Brain Pathol"},{"issue":"3 pt 1","key":"10.1016\/j.neurol.2016.10.009_bib0460","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0465","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","article-title":"The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease","volume":"52","author":"Delacourte","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.10.009_bib0470","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0197-4580(97)80306-5","article-title":"Modeling the relation between neurofibrillary tangles and intellectual status","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0475","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-142292","article-title":"Mapping the progression of atrophy in early- and late-onset Alzheimer's disease","volume":"46","author":"Migliaccio","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0001-2998(86)80002-2","article-title":"Positron emission tomography imaging of regional cerebral glucose metabolism","volume":"16","author":"Alavi","year":"1986","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0485","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00001756-200103260-00045","article-title":"Impaired cerebral glucosemetabolism and cognitive functioning predict deterioration in mild cognitive impairment","volume":"12","author":"Arnaiz","year":"2001","journal-title":"NeuroReport"},{"issue":"8","key":"10.1016\/j.neurol.2016.10.009_bib0490","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?","volume":"60","author":"Chetelat","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0495","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","article-title":"Hippocampal formation glucose metabolism and volume losses in MCI and AD","volume":"22","author":"De Santi","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.neurol.2016.10.009_bib0500","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2016.10.009_bib0505","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?","volume":"60","author":"Ch\u00e9telat","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0515","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1096-7192(03)00139-2","article-title":"Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET","volume":"80","author":"Silverman","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0520","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1742-1241.2011.02845.x","article-title":"Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment","volume":"66","author":"Zhang","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0525","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neurobiolaging.2010.03.011","article-title":"Cognition, glucose metabolism and amyloid burden in Alzheimer's disease","volume":"33","author":"Furst","year":"2012","journal-title":"Neurobiol Aging."},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0530","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410320311","article-title":"Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease","volume":"32","author":"Stern","year":"1992","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0535","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.154.2.165","article-title":"Association of premorbid intellectual functionwith cerebral metabolism in Alzheimer'sdisease: Implicationsforthe cognitive reserve hypothesis","volume":"154","author":"Alexander","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0540","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00415-015-7738-z","article-title":"Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes","volume":"262","author":"Mat\u00edas-Guiu","year":"2015","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2016.10.009_bib0545","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/jnnp.74.11.1521","article-title":"The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET","volume":"74","author":"Nestor","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0550","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-014-0093-y","article-title":"Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography","volume":"7","author":"Sha","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0555","first-page":"399","article-title":"Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy","volume":"2","author":"Oshima","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.neurol.2016.10.009_bib0560","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archneurol.2010.78","article-title":"Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants","volume":"67","author":"Josephs","year":"2010","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2016.10.009_bib0565","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/mds.23062","article-title":"Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease","volume":"25","author":"Josephs","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0570","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0575","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-141110","article-title":"Differentiating the frontal presentation of Alzheimer's disease with FDG-PET","volume":"44","author":"Woodward","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"pt 9","key":"10.1016\/j.neurol.2016.10.009_bib0580","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0585","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11682-010-9108-x","article-title":"Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?","volume":"5","author":"Fong","year":"2011","journal-title":"Brain Imaging Behav"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0590","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","article-title":"Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease","volume":"47","author":"Albin","year":"1996","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2016.10.009_bib0595","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2003.10.007","article-title":"Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study","volume":"25","author":"Diehl","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2016.10.009_bib0600","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awn012","article-title":"Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study","volume":"131","author":"Le Ber","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0447.2000.101001011.x","article-title":"PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review","volume":"101","author":"Videbech","year":"2000","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0610","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-3223(01)01216-1","article-title":"Regional cerebral glucose utilization in patients with a range of severities of unipolar depression","volume":"51","author":"Kimbrell","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0615","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1176\/appi.ajp.158.6.899","article-title":"Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression","volume":"158","author":"Kennedy","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"17","key":"10.1016\/j.neurol.2016.10.009_bib0620","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0625","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00415-011-6308-2","article-title":"Striatal hypermetabolism in limbic encephalitis","volume":"259","author":"Rey","year":"2012","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0630","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0001-2998(05)80239-9","article-title":"Brain imaging in acquired immunodeficiency syndrome dementia complex","volume":"20","author":"Kramer","year":"1990","journal-title":"Semin Nucl Med"},{"issue":"7","key":"10.1016\/j.neurol.2016.10.009_bib0635","first-page":"1133","article-title":"Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia","volume":"37","author":"Rottenberg","year":"1996","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.neurol.2016.10.009_bib0640","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0645","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0650","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.1016\/j.neurol.2016.10.009_bib0655","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2016.10.009_bib0660","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000165917","article-title":"Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria","volume":"26","author":"Aarsland","year":"2008","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"11","key":"10.1016\/j.neurol.2016.10.009_bib0665","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with Lewy bodies: a comparison of clinical diagnosis. FP-CIT single photon emission computed tomography imaging and autopsy","volume":"78","author":"Walker","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0670","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0675","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000113417","article-title":"Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers","volume":"25","author":"Aarsland","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0680","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0685","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"K\u00e4gi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.neurol.2016.10.009_bib0690","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.21505","article-title":"Role of DAT-SPECT in the diagnostic work up of parkinsonism","volume":"22","author":"Scherfler","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0695","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3988\/jcn.2006.2.1.51","article-title":"Clinical implications of cardiac-MIBG SPECT in the differentiation of parkinsonian syndromes","volume":"2","author":"Shin","year":"2006","journal-title":"J Clin Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2016.10.009_bib0700","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/mds.23659","article-title":"Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders","volume":"26","author":"King","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","article-title":"Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"J Neuroimaging"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0710","doi-asserted-by":"crossref","first-page":"e0120540","DOI":"10.1371\/journal.pone.0120540","article-title":"Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study","volume":"10","author":"Yoshita","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2016.10.009_bib0715","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24717","article-title":"123 I-FP-CIT SPECT and 123 I-MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study","author":"Tiraboschi","year":"2016","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2016.10.009_bib0720","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","article-title":"131I\/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0835","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0730","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of Florbetapir-PET for imaging \u03b2-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neurol.2016.10.009_bib0740","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2016.10.009_bib0745","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12603-014-0507-3","article-title":"Amyloid imaging in Alzheimer's disease: a literature review","volume":"18","author":"Saidlitz","year":"2014","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0750","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2967\/jnumed.115.161927","article-title":"Impact of training method on the robustness of the visual assessment of 18F-florbetaben PET scans: results from a Phase 3 trial","volume":"57","author":"Seibyl","year":"2016","journal-title":"J Nucl Med"},{"issue":"Pt 6","key":"10.1016\/j.neurol.2016.10.009_bib0755","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"issue":"19","key":"10.1016\/j.neurol.2016.10.009_bib0760","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.neurol.2016.10.009_bib0765","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.neurol.2016.10.009_bib0770","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0775","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2016.10.009_bib0780","first-page":"82","article-title":"The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment","volume":"10","author":"Grimmer","year":"2013","journal-title":"Curr Alzheimer Res"},{"issue":"pt11","key":"10.1016\/j.neurol.2016.10.009_bib0785","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2016.10.009_bib0790","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.psym.2015.12.002","article-title":"Florbetapir F18 PET amyloid neuroimaging and characteristics in patients with mild and moderate Alzheimer dementia","volume":"57","author":"Degenhardt","year":"2016","journal-title":"Psychosomatics"},{"issue":"6\u20137","key":"10.1016\/j.neurol.2016.10.009_bib0795","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neurol.2010.10.007","article-title":"Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice","volume":"167","author":"Koric","year":"2011","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0800","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0805","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Alzheimer's Disease Neuroimaging Initiative. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.10.009_bib0810","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.neurol.2016.10.009_bib0815","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2016.10.009_bib0820","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/WAD.0b013e31815c3445","article-title":"Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions","volume":"21","author":"Rascovsky","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Pt 5","key":"10.1016\/j.neurol.2016.10.009_bib0825","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2016.10.009_bib0830","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T06:57:27Z","timestamp":1601189847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716300595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0035378716300595"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.10.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular imaging in the diagnosis of Alzheimer's disease and related disorders","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}